Form 4 for NAUT Nautilus Biotechnology, Inc.
Accepted 2024-03-11 00:00:00 ET · period of report 2024-03-08 · accession 0001808805-24-000026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-11 | 2024-03-08+ | NAUT | Patel Sujal M | CEO, Pres, Sec, Dir, 10% | P - Purchase | $2.87 | +14.5K | 10.06M | +0.1% | +$41.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-08 | P | A | 2,430 | $2.99 | 10,052,444 | D | — | — | (F1) Represents the weighted average share price of an aggregate total of 2,430 shares purchased in the price range of $2.96 to $3.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |
| 2 | Common | Common Stock | 2024-03-11 | P | A | 12,044 | $2.84 | 10,064,488 | D | — | — | (F2) Represents the weighted average share price of an aggregate total of 12,044 shares purchased in the price range of $2.75 to $3.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |